← Open Payments lookup

NERISSA VAZQUEZ ARROYO: Open Payments

NPI 1174025449 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,580 in 71 payments from 13 companies in 2025. Trend: 2023 $987 · 2024 $1,587 · 2025 $2,580

Food & beverage: $2,580
CompanyPaymentsAmount
Gilead Sciences, Inc.33$691
Madrigal Pharmaceuticals15$638
Janssen Biotech, Inc.6$254
Ipsen Biopharmaceuticals, Inc4$224
GENZYME CORPORATION2$171
Mallinckrodt Hospital Products Inc.1$146
Aimmune Therapeutics, Inc.1$125
AstraZeneca Pharmaceuticals LP1$122
Mirum Pharmaceuticals, Inc.2$73
Takeda Pharmaceuticals U.S.A., Inc.2$60

Products named: REZDIFFRA, TREMFYA, IQIRVO, DUPIXENT, TERLIVAZ, ZENPEP, Vemlidy, Livmarli.

Industry payments across HI — which companies pay providers there.